サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1564985

インターベンショナル・カーディオロジー機器の世界市場

Interventional Cardiology Devices

出版日
ページ情報
英文 184 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.66円
インターベンショナル・カーディオロジー機器の世界市場
出版日: 2024年10月04日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 184 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

インターベンショナル・カーディオロジー機器の世界市場は2030年までに264億米ドルに達する見込み

2023年に168億米ドルと推定されたインターベンショナル・カーディオロジー機器の世界市場は、2030年には264億米ドルに達し、分析期間2023-2030年のCAGRは6.7%で成長すると予測されます。本レポートで分析したセグメントの1つである血管形成術用バルーンは、CAGR 7.2%を記録し、分析期間終了時には73億米ドルに達すると予測されます。血管形成術用ステントセグメントの成長率は、分析期間中CAGR 7.2%と推定されます。

米国市場は推定45億米ドル、中国はCAGR11.2％で成長予測

米国のインターベンショナル・カーディオロジー機器市場は2023年に45億米ドルと推定されます。世界第2位の経済大国である中国は、2023年から2030年の分析期間においてCAGR 11.2%で推移し、2030年には65億米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.7%と6.5%と予測されています。欧州では、ドイツがCAGR 3.4%で成長すると予測されています。

世界のインターベンショナル・カーディオロジー機器市場- 主要動向と促進要因のまとめ

技術革新はインターベンショナル・カーディオロジー機器市場にどのような影響を与えているか？

技術革新はインターベンショナル・カーディオロジー機器市場の主要な原動力であり、患者の予後と手技効率を改善する先進デバイスの市場開拓につながっています。生体吸収性ステントや薬剤溶出ステントのイントロダクションなど、最近のステント技術の進歩により、従来の金属製ステントに伴う合併症が大幅に減少しました。さらに、血管内超音波（IVUS）や光干渉断層計（OCT）などの画像技術の革新により、手技中の洞察がより明確になり、心臓専門医がより正確な判断を下せるようになっています。ロボット工学と人工知能のインターベンショナル・カーディオロジーへの統合も増加傾向にあり、精密で低侵襲な手技を容易にすることで、回復時間を短縮し、患者の快適性を高めています。これらの技術が進化し続けることで、心血管疾患の診断と治療に新たな可能性を提供し、市場のさらなる成長と変革が促進されることが期待されます。

なぜ心血管疾患の有病率の増加が市場の需要を促進しているのか？

心血管疾患（CVD）の有病率の増加は、インターベンショナル・カーディオロジー機器の需要を促進する重要な要因です。冠動脈疾患、心臓発作、脳卒中などのCVDは、高齢化、不健康な生活習慣、肥満、喫煙などの要因によって、依然として世界の死亡原因の上位を占めています。このような疾病の負担の増大により、早期回復、入院期間の短縮、ヘルスケアコストの削減を実現する低侵襲治療に対する需要が高まっています。血管形成術、ステント留置術、アテレクトミーなどのインターベンショナル・カーディオロジー手技は、従来の外科的手技に代わる効果的な選択肢を提供するため、一般的になりつつあります。このような低侵襲ソリューションに対する需要の高まりが、先進的なインターベンショナル・カーディオロジー機器の採用を促進し、市場の成長を後押ししています。

今後の成長見通しを形成する新興市場の役割とは？

新興市場は、インターベンショナル・カーディオロジー機器市場の今後の成長見通しを形成する上で重要な役割を果たしています。アジア太平洋、ラテンアメリカ、中東の国々では、ヘルスケアインフラの急速な成長、ヘルスケア支出の増加、医療サービスへのアクセスの改善が見られます。さらに、これらの地域では都市化、ライフスタイルの変化、平均寿命の伸びにより、心血管疾患の有病率が上昇しており、先進的なインターベンショナル・カーディオロジー機器に対する大きな需要が生まれています。これらの市場の政府もヘルスケア改革に積極的に投資しており、専門的な心臓病学サービスの充実に注力しています。さらに、低侵襲手技に対する意識の高まりや多くの患者プールの存在は、市場プレーヤーが拠点を拡大し、これらの高成長地域に参入する有利な機会を提供しています。

インターベンショナル・カーディオロジー機器市場の成長はどのような要因によってもたらされているのか？

インターベンショナル・カーディオロジー機器市場の成長は、心血管疾患の有病率の増加、デバイス技術の進歩、新興市場におけるヘルスケアインフラの拡大など、いくつかの要因によってもたらされます。薬剤溶出性ステント、生体吸収性血管足場、次世代画像システムなどの革新的なデバイスの継続的な開発により、インターベンショナル手技の有効性と安全性が向上し、ヘルスケアプロバイダー間での採用率が高まっています。また、患者の低侵襲治療に対する意識の高まりや嗜好も、インターベンショナル・カーディオロジー機器の需要を押し上げています。さらに、世界人口の高齢化と高血圧や糖尿病などの危険因子の罹患率の増加が市場成長にさらに寄与しています。新興国がヘルスケアの近代化に投資し、高度な心臓病学サービスへのアクセスを拡大しているため、インターベンショナル・カーディオロジー機器市場は今後数年で力強い成長を遂げるでしょう。

調査対象企業の例（全22件）

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • Cook Medical, Inc.
  • Johnson & Johnson
  • Medtronic, Inc.
  • Smiths Medical
  • Terumo Corporation

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP15891

Global Interventional Cardiology Devices Market to Reach US$26.4 Billion by 2030

The global market for Interventional Cardiology Devices estimated at US$16.8 Billion in the year 2023, is expected to reach US$26.4 Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2023-2030. Angioplasty Balloons, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$7.3 Billion by the end of the analysis period. Growth in the Angioplasty Stents segment is estimated at 7.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$4.5 Billion While China is Forecast to Grow at 11.2% CAGR

The Interventional Cardiology Devices market in the U.S. is estimated at US$4.5 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$6.5 Billion by the year 2030 trailing a CAGR of 11.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.7% and 6.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR.

Global Interventional Cardiology Devices Market - Key Trends & Drivers Summarized

How Are Technological Innovations Impacting the Interventional Cardiology Devices Market?

Technological innovations have been a major driving force in the interventional cardiology devices market, leading to the development of advanced devices that improve patient outcomes and procedural efficiency. Recent advancements in stent technology, such as the introduction of bioresorbable stents and drug-eluting stents, have significantly reduced complications associated with traditional metal stents. Furthermore, innovations in imaging technologies, including intravascular ultrasound (IVUS) and optical coherence tomography (OCT), are providing clearer insights during procedures, enabling cardiologists to make more accurate decisions. The integration of robotics and artificial intelligence into interventional cardiology is also on the rise, facilitating precise and minimally invasive procedures, which reduce recovery times and enhance patient comfort. As these technologies continue to evolve, they are expected to drive further growth and transformation in the market, offering new possibilities for the diagnosis and treatment of cardiovascular diseases.

Why Is the Growing Prevalence of Cardiovascular Diseases Fueling Market Demand?

The growing prevalence of cardiovascular diseases (CVDs) is a critical factor fueling the demand for interventional cardiology devices. CVDs, including coronary artery disease, heart attacks, and stroke, remain the leading cause of mortality worldwide, driven by factors such as aging populations, unhealthy lifestyles, obesity, and smoking. The increasing burden of these diseases has led to a higher demand for minimally invasive procedures that offer quicker recovery, reduced hospital stays, and lower healthcare costs. Interventional cardiology procedures, such as angioplasty, stenting, and atherectomy, are becoming more common as they provide effective alternatives to traditional surgical methods. This rising demand for minimally invasive solutions is driving the adoption of advanced interventional cardiology devices, thereby boosting market growth.

What Role Do Emerging Markets Play in Shaping Future Growth Prospects?

Emerging markets are playing a significant role in shaping the future growth prospects of the interventional cardiology devices market. Countries in Asia-Pacific, Latin America, and the Middle East are experiencing rapid growth in healthcare infrastructure, increased healthcare spending, and improved access to medical services. Additionally, the rising prevalence of cardiovascular diseases in these regions, due to urbanization, lifestyle changes, and increased life expectancy, is creating substantial demand for advanced interventional cardiology devices. Governments in these markets are also actively investing in healthcare reforms and are focusing on enhancing the availability of specialized cardiology services. Moreover, the growing awareness about minimally invasive procedures and the presence of a large patient pool present lucrative opportunities for market players to expand their footprint and tap into these high-growth regions.

How Is the Growth in the Interventional Cardiology Devices Market Driven by Several Factors?

The growth in the interventional cardiology devices market is driven by several factors, including the increasing prevalence of cardiovascular diseases, advancements in device technology, and the expansion of healthcare infrastructure in emerging markets. The continuous development of innovative devices, such as drug-eluting stents, bioresorbable vascular scaffolds, and next-generation imaging systems, is enhancing the effectiveness and safety of interventional procedures, driving higher adoption among healthcare providers. The rising awareness and preference for minimally invasive procedures among patients are also boosting the demand for interventional cardiology devices. Additionally, the aging global population and the growing incidence of risk factors like hypertension and diabetes are further contributing to market growth. As emerging economies invest in healthcare modernization and expand access to advanced cardiology services, the market for interventional cardiology devices is set to experience robust growth in the coming years.

Select Competitors (Total 22 Featured) -

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • Cook Medical, Inc.
  • Johnson & Johnson
  • Medtronic, Inc.
  • Smiths Medical
  • Terumo Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Interventional Cardiology Devices - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Adoption of Minimally Invasive Procedures Driving Market Growth
    • Technological Advancements in Stent Designs Enhancing Patient Outcomes
    • Rising Prevalence of Cardiovascular Diseases Boosting Demand for Cardiology Devices
    • Growing Preference for Drug-Eluting Balloons Over Traditional Stents
    • Development of Bioabsorbable Stents as a Sustainable Alternative
    • Integration of Imaging Technologies in Interventional Devices Improving Precision
    • Expanding Geriatric Population Base Leading to Higher Procedure Volumes
    • Growing Investments in R&D Leading to Innovative Device Launches
    • Surge in Demand for Hybrid Operating Rooms Enhancing Surgical Capabilities
    • Regulatory Approvals and Favorable Reimbursement Policies Driving Market Adoption
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Interventional Cardiology Devices Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Interventional Cardiology Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Interventional Cardiology Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Angioplasty Balloons by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Angioplasty Balloons by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Angioplasty Balloons by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Angioplasty Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Angioplasty Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Angioplasty Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Structural Heart Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Structural Heart Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Structural Heart Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Catheters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Plaque Modification Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Plaque Modification Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Plaque Modification Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hemodynamic Flow Alteration Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Hemodynamic Flow Alteration Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Hemodynamic Flow Alteration Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Device Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other Device Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Other Device Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Interventional Cardiology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030
  • JAPAN
    • Interventional Cardiology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030
  • CHINA
    • Interventional Cardiology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 35: China Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: China Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: China 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030
  • EUROPE
    • Interventional Cardiology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 38: Europe Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 39: Europe Historic Review for Interventional Cardiology Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Europe 16-Year Perspective for Interventional Cardiology Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 41: Europe Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Europe Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Europe 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030
  • FRANCE
    • Interventional Cardiology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 44: France Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: France Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: France 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030
  • GERMANY
    • Interventional Cardiology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 47: Germany Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Germany Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Germany 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 50: Italy Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Italy Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Italy 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Interventional Cardiology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 53: UK Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: UK Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: UK 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 56: Spain Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Spain Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Spain 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 59: Russia Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Russia Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Russia 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 62: Rest of Europe Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Rest of Europe Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Rest of Europe 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Interventional Cardiology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 65: Asia-Pacific Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 66: Asia-Pacific Historic Review for Interventional Cardiology Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Asia-Pacific 16-Year Perspective for Interventional Cardiology Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 68: Asia-Pacific Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Asia-Pacific Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Asia-Pacific 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Interventional Cardiology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 71: Australia Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Australia Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Australia 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030
  • INDIA
    • Interventional Cardiology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 74: India Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: India Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: India 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 77: South Korea Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: South Korea Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: South Korea 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 80: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Rest of Asia-Pacific Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Rest of Asia-Pacific 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Interventional Cardiology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 83: Latin America Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 84: Latin America Historic Review for Interventional Cardiology Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Latin America 16-Year Perspective for Interventional Cardiology Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 86: Latin America Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Latin America Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Latin America 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 89: Argentina Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Argentina Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Argentina 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 92: Brazil Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Brazil Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Brazil 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 95: Mexico Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Mexico Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Mexico 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 98: Rest of Latin America Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of Latin America Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of Latin America 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Interventional Cardiology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 101: Middle East Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 102: Middle East Historic Review for Interventional Cardiology Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Middle East 16-Year Perspective for Interventional Cardiology Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 104: Middle East Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Middle East Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Middle East 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 107: Iran Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Iran Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Iran 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 110: Israel Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Israel Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Israel 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 113: Saudi Arabia Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Saudi Arabia Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Saudi Arabia 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 116: UAE Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: UAE Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: UAE 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 119: Rest of Middle East Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Rest of Middle East Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: Rest of Middle East 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030
  • AFRICA
    • Interventional Cardiology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 122: Africa Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Africa Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Africa 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030

IV. COMPETITION